| Bid Price | 0.06p | High Price | 0.06p |
|---|
| Ask Price | 0.07p | Low Price | 0.05p |
|---|
| Open Price | 0.06p | Spread | 15.38% |
|---|
| Prev Close | 0.06p | Volume | 5,510,045 |
|---|
Nuformix PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Oct 11, 2024 | 0.06 | 0.06 | 0.05 | 0.06 | 5,510,045 |
| Oct 10, 2024 | 0.06 | 0.06 | 0.05 | 0.06 | 15,622,858 |
| Oct 9, 2024 | 0.06 | 0.06 | 0.06 | 0.06 | 1,253,613 |
| Oct 8, 2024 | 0.07 | 0.07 | 0.06 | 0.06 | 38,115,809 |
| Oct 7, 2024 | 0.06 | 0.07 | 0.05 | 0.06 | 37,077,891 |
Nuformix PLC Information
| Name | Nuformix PLC | Index | |
|---|
| ISIN | GB00BYW79Y38 | Epic | NFX |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | SET3 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 1,500,000 | Trading Status | Closed |
|---|
| Shares in Issue | 819.31 m | Prev Close | 0.06p |
|---|
| PE Ratio | | Market Cap | £491,585.62 |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | £-0.00 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | n/a | DPS Growth (%) | 0 |
|---|
| Current Ratio | 1.115864 | Quick Ratio | 0.849394 |
|---|
Nuformix PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 10/01/22 | BUY | Alastair Riddell | RES | 400,000 @ £0.01 | £4,700.00 |
| 16/09/21 | BUY | Alastair Riddell | RES | 350,000 @ £0.01 | £4,725.00 |
| 30/03/21 | PLAC | Karl Keegan | RES | 250,000 @ £0.02 | £5,000.00 |
| 30/03/21 | PLAC | Madeleine Kennedy | NED | 250,000 @ £0.02 | £5,000.00 |
| 30/03/21 | PLAC | Julian Gilbert | NED | 250,000 @ £0.02 | £5,000.00 |
| 30/03/21 | PLAC | Anne Brindley | RES | 500,000 @ £0.02 | £10,000.00 |
| 05/02/20 | SELL | David Tapolczay | RES | 650,000 @ £0.09 | £56,550.00 |
| 28/09/18 | BUY | Kirk Siderman-Wolter | RES | 35,364 @ £0.03 | £919.00 |
Nuformix PLC News
